ICICI Pru Nfty Phrm Idx

All Cap

Diversified

Equity

India Defensive

Others

Empty

1–7 yearsInvestment Horizon

HNI,MATarget Segments

Empty

What This Strategy Does

ICICI Pru Nfty Phrm Idx Reg Gr is an equity fund which captures India's ₹1.5 trillion healthcare opportunity through a passive index-tracking approach, deploying capital across leading pharmaceutical and healthcare companies to achieve benchmark-aligned compounding.

Performance and Risk Analysis

Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.

Fund Performance

0.0% AnnuallyAlpha

+0.0% vs +0.0% benchmarkSince Inception

+0.0% vs +0.0% benchmark3Y Annualized

+0.0% vs +0.0% benchmark5Y Annualized

ICICI Pru Nfty Phrm Idx

Benchmark Index

Benchmark Performance Comparison

Icici Prudential Nifty Pharma Index Fund

NIFTY 50

Given the product’s limited performance history, the assessment considers the fund house’s track record and the historical performance of comparable strategies managed by the same fund house, which follow similar investment approaches. Such comparisons provide historical context only and do not represent the performance of the new product or indicate its future returns.

Risk Profile

Standard Deviation13.7%

Maximum Drawdown-15.3% | Jan 2025

Sharpe Ratio0.74

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.

Strategy Details

A closer look at the investment thesis, portfolio construction, and current holdings.

Core Investment Theme

Provides targeted exposure to India's pharmaceutical and healthcare companies—sectors poised for long-term growth driven by rising incomes, lifestyle diseases, and an aging population. This theme captures the secular tailwinds propelling India's healthcare industry.

Portfolio Holdings Overview

SectoralAllocation

Services100%

Geographic Allocation

Domestic100%

Top Stock Holdings

CompanySectorAllocation

Sun Pharmaceuticals Industries LtdServices21.33%

Divi's Laboratories LtdServices10.36%

Cipla LtdServices8.39%

Torrent Pharmaceuticals LtdServices7.60%

Laurus Labs LtdServices7.15%

Dr Reddy's Laboratories LtdServices7.08%

Lupin LtdServices5.94%

Aurobindo Pharma LtdServices4.43%

Alkem Laboratories LtdServices3.40%

Glenmark Pharmaceuticals LtdServices3.40%

Fund House Management

The asset management company’s track record, AUM scale, and fund manager credentials.

Fund Manager Track Record

Nishit Patel

Lead Portfolio Manager

Mr. Nishit Patel has experience of 9 years. Manages 228 funds at ICICI Prudential Asset Management Co Ltd with an AUM of approximately ₹94 Cr Holds a B.Com degree.

Ashwini Bharucha

Co-Portfolio Manager

Ashwini Bharucha has experience of 2 years. Manages 218 funds at ICICI Prudential Asset Management Co Ltd with an AUM of approximately ₹94 Cr

CW Expert Take

ICICI Prudential combines scale with specialization. Their investment philosophy centers on understanding business economics rather than following market momentum. The fund house has built distinct expertise across asset classes, from equity research teams focused on sectoral deep-dives to fixed income desks with strong credit assessment capabilities.

11 years

Combined Team Experience

₹ 188 Cr

Assets Under Management

Firm Overview

AMCICICI Prudential Asset Management Co Ltd

Operational & Regulatory Details

What it costs to invest, transaction mechanics, and regulatory disclosures you should know.

Costs and Fees

Total Expense Ratio (TER)1.15%

Regulatory & Tax Information

INF109KC18L6

ISIN

DailyDealing Frequency

LTCG | >1Year 12.5%% on gain above 1.25 Lakh

STCG | <1Year 20%%

Tax Implications (India)